Federation des caisses Desjardins du Quebec’s Regencell Bioscience RGC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$56.7K	Buy	+2,231	New	+$63.1K	﹤0.01%	1826

Other funds holding RGC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RGC Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Regencell Bioscience (RGC) in Q1 2026: 2,231 shares worth $56.7K. The stake represents ﹤0.01% of the portfolio and ranks #1826 among its holdings.

31 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

Federation des caisses Desjardins du Quebec held 2,231 shares of Regencell Bioscience worth $56.7K as of Q1 2026.
Regencell Bioscience was a new Federation des caisses Desjardins du Quebec position in Q1 2026.
Regencell Bioscience made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1826 holding.
31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.